Edoxaban for venous thromboembolism

Edoxaban for venous thromboembolism - Edoxaban for venous thromboembolism

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050893

Enrollment

8000

Registered

2023-04-20

Start date

2023-03-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: VTE

Exclusion criteria

Exclusion criteria: Anticoagulation other than for VTE

Design outcomes

Primary

Measure	Time frame
Recurrent VTE, Major bleeding	—

Countries

Japan

Contacts

Public ContactYugo Yamashita

Graduate School of Medicine, Kyoto University. Department of Cardiovascular Medicine

yyamashi@kuhp.kyoto-u.ac.jp+81-75-751-4254

Outcome results